期刊文献+

对36例老年2型糖尿病患者临床分析 被引量:2

下载PDF
导出
摘要 目的:探究老年2型糖尿病的临床治疗方法和治疗效果。方法:选择我院2011年12月-2012年12月收治的老年2型糖尿病36例,观察分析患者的血糖含量、生命体征、并发症及过敏史和禁忌史,根据患者不同的临床特点,选择个体化的血糖控制原则,制定针对性治疗方法。结果:所有患者的血糖水平均有所下降,与治疗前血糖水平相比存在显著差异(P<0.05),具有统计学意义。结论:对老年2型糖尿病患者选择个体化的血糖控制原则,根据患者不同的临床特点实施针对性治疗,能有效降低血糖水平,减轻患者痛苦,提高治疗有效率。
作者 丁大年
机构地区 芜湖玛丽娅医院
出处 《求医问药(下半月)》 2013年第9期98-99,共2页 Seek Medical and Ask The Medicine
  • 相关文献

参考文献4

  • 1彭仙珍,徐标,肖政.厄贝沙坦联合低分子肝素钠治疗2型糖尿病肾病的疗效及安全性[J].临床荟萃,2009,24(15):1355-1357. 被引量:6
  • 2Ratanawongsa N,Handley MA,Quan J,et al.Quasi-experimental trial of diabetes SelfManagement Automated and Real-Time Telephonic Support(SMARTSteps)in a Medicaid managed cara plan:study protuocol[].BMC Health Sarv Res.2012 被引量:1
  • 3Parati G,Bilo G,Ochoa JE.Benefits of tight blood pressure control in di-abetic patients with hypertension:importance of early and sustained im-plementation of effective treatment strategies[].Diabetes Care.2011 被引量:1
  • 4Oh HG,Rhee EJ,Kim TW,etal.Higher glycated hemoglobin level is associated with increated risk for ischemic stroke in non-disbetic Korean male adults[].Diabetes Metab J.2011 被引量:1

二级参考文献10

  • 1许红,胡日红.低分子肝素与普通肝素对血透患者血脂的影响[J].浙江中西医结合杂志,2007,17(1):20-21. 被引量:4
  • 2Rossing K, Schjoedt KJ, Jensen BR, et al. Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria[J]. Kidney Int,2005,68(6):1190-1198. 被引量:1
  • 3Sasso FC,Carbonara O,Persico M,et al. Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetie patients independently of hypertension: a randomized doubleblind placebo-controlled crossover study [J]. Diabetes Care, 2002,25(8):1909-1913. 被引量:1
  • 4Cetinkalp SS, Karadeniz MM, Erdogan MA, et al. Short-term effects ofirbesartan treatment on microalbuminuria in patients with normotensive type 2 diabetes[J]. Saudi Med J, 2008,29 (10):1414-1418. 被引量:1
  • 5Leidig M,Bambauer R,Kirchertz EJ ,et al. Efficacy, safety and tolerability of valsartan 80 mg compared to irbesartan 150 mg in hypertensive patients on long-term hemodialysis (VALID study)[J]. Clin Nephrol,2008,69(6) :425-432. 被引量:1
  • 6Ofili EO, Cable G, Neutel J M, at al. Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women:the inclusive trial[J]. J Womens Health (Larchmt), 2008,17(6) :931-938. 被引量:1
  • 7Deepa PR, Varalakshmi P. The cytoprotective role of a low-molecular-weight heparin fragment studied in an experimental model of glomerulotoxicity[J]. Eur J Pharmacol, 2003,478(2/ 3):199-205. 被引量:1
  • 8Rajeswari A, Varalakshmi P. Low molecular weight heparin protection against oxalate-induced oxidative renal insult [J]. Clin Chim Acta,2006,370(1/2):108-114. 被引量:1
  • 9Nasstrom B,Stegmayr B,Gupta J ,et al. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing [J]. Nephrol Dial Transplant, 2005,20 (5) : 1172. 被引量:1
  • 10郭志新,邱明才.血管紧张素II上调肾小球系膜细胞TGF-β受体的表达[J].山西医科大学学报,2003,34(6):494-497. 被引量:9

共引文献5

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部